HPV-positive head and neck tumours, a distinct clinical entity
- PMID: 26563006
HPV-positive head and neck tumours, a distinct clinical entity
Abstract
A worldwide rise in the incidence of oropharyngeal squamous cell cancer has been recorded over the past decade. This rise has been attributed to an increase in oncogenic human papilloma virus (HPV) infections. The biology of HPV-positive oropharyngeal cancer is distinct; it includes p53 degradation, retinoblastoma pathway inactivation, and p16 upregulation. The best method for detecting HPV in tumour material is controversial; both in-situ hybridisation and PCR are commonly used. However, p16 can serve as a potential surrogate marker, and therefore, p16 immunohistochemistry is widely used in clinical practice. Compared to HPV-negative cancers, HPV-positive oropharyngeal cancer appears to be more responsive to chemotherapy and radiotherapy. Thus, p16 can serve as a prognostic marker for enhanced overall survival and disease-free survival. In this review, we aimed to highlight the current understanding of the epidemiology, biology, detection, and management of HPV-related oropharyngeal head and neck squamous cell carcinoma.
Similar articles
-
Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.Hum Pathol. 2016 Apr;50:51-61. doi: 10.1016/j.humpath.2015.11.001. Epub 2015 Nov 17. Hum Pathol. 2016. PMID: 26997438
-
HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice.Semin Diagn Pathol. 2015 Sep;32(5):344-51. doi: 10.1053/j.semdp.2015.02.013. Epub 2015 Feb 4. Semin Diagn Pathol. 2015. PMID: 25724476 Review.
-
The New Face of Head and Neck Cancer: The HPV Epidemic.Oncology (Williston Park). 2015 Sep;29(9):616-26. Oncology (Williston Park). 2015. PMID: 26384796 Review.
-
HPV-associated head and neck cancer: a virus-related cancer epidemic.Lancet Oncol. 2010 Aug;11(8):781-9. doi: 10.1016/S1470-2045(10)70017-6. Epub 2010 May 5. Lancet Oncol. 2010. PMID: 20451455 Free PMC article. Review.
-
A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression.J Oral Pathol Med. 2016 Jul;45(6):399-408. doi: 10.1111/jop.12378. Epub 2015 Oct 22. J Oral Pathol Med. 2016. PMID: 26493274 Free PMC article.
Cited by
-
Outcomes after primary intensity-modulated radiation therapy for oropharyngeal squamous cell carcinoma at a New Zealand regional cancer centre: Impact of p16 status.Cancer Rep (Hoboken). 2018 Jun;1(1):e1001. doi: 10.1002/cnr2.1001. Epub 2018 Apr 10. Cancer Rep (Hoboken). 2018. PMID: 32729235 Free PMC article.
-
The impact of radiomics for human papillomavirus status prediction in oropharyngeal cancer: systematic review and radiomics quality score assessment.Neuroradiology. 2022 Aug;64(8):1639-1647. doi: 10.1007/s00234-022-02959-0. Epub 2022 Apr 23. Neuroradiology. 2022. PMID: 35459957 Free PMC article.
-
Prognostic value of HPV-PCR, p16 and p53 immunohistochemical status on local recurrence rate and survival in patients with vulvar squamous cell carcinoma.Virchows Arch. 2024 Jun;484(6):985-994. doi: 10.1007/s00428-023-03690-8. Epub 2023 Nov 8. Virchows Arch. 2024. PMID: 37938322 Free PMC article.
-
Amide proton transfer imaging for the determination of human papillomavirus status in patients with oropharyngeal squamous cell carcinoma.Medicine (Baltimore). 2022 Jul 15;101(28):e29457. doi: 10.1097/MD.0000000000029457. Medicine (Baltimore). 2022. PMID: 35839055 Free PMC article.
-
Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant.Clin Cancer Res. 2018 Oct 15;24(20):5123-5132. doi: 10.1158/1078-0432.CCR-18-0752. Epub 2018 Jun 26. Clin Cancer Res. 2018. PMID: 29945995 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous